Acorah Software Products - Accounts Production 16.8.200 false true 31 March 2024 1 April 2023 false true No description of principal activity 1 April 2024 31 March 2025 31 March 2025 14012541 Mr Leonard Aligwekwe Eluma iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14012541 2024-03-31 14012541 2025-03-31 14012541 2024-04-01 2025-03-31 14012541 frs-core:CurrentFinancialInstruments 2025-03-31 14012541 frs-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 14012541 frs-bus:FilletedAccounts 2024-04-01 2025-03-31 14012541 frs-bus:Micro-entities 2024-04-01 2025-03-31 14012541 frs-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 14012541 frs-bus:Director1 2024-04-01 2025-03-31 14012541 2023-03-31 14012541 2024-03-31 14012541 2023-04-01 2024-03-31 14012541 frs-core:CurrentFinancialInstruments 2024-03-31
Registered number: 14012541
Lut3 Pharm Ltd
Unaudited Financial Statements
For The Year Ended 31 March 2025
Balance Sheet
Registered number: 14012541
2025 2024
£ £
Current assets 5,301 1,882
Creditors: Amounts Falling Due Within One Year (1,911 ) (382 )
NET CURRENT ASSETS 3,390 1,500
TOTAL ASSETS LESS CURRENT LIABILITIES 3,390 1,500
NET ASSETS 3,390 1,500
CAPITAL AND RESERVES 3,390 1,500

Notes

1. General Information
Lut3 Pharm Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14012541 . The registered office is 1 Fairebourne Road, Tottenham, London, N17 6TP.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2024: 1)
1 1
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Leonard Aligwekwe Eluma
Director
27/12/2025